Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-16T14:22:36.846Z Has data issue: false hasContentIssue false
  • English
  • Français

A Much-Needed Perspective

Published online by Cambridge University Press:  18 November 2022

H. Paul Chin
H. Paul Chin*
Affiliation:
Department of Psychiatry, Sutter Health California Pacific Medical Center, San Francisco, California 94114, USA
*
Corresponding author. Email: ChinP@sutterhealth.org
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
Cambridge Quarterly of Healthcare Ethics , Volume 31 , Issue 4 , October 2022 , pp. 496 - 497
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Soofi, H. Using antipsychotics for self-defence purposes by care staff in residential aged care facilities: An ethical analysis. Cambridge Quarterly of Healthcare Ethics 2022;31(4)CrossRefGoogle Scholar.

2 Global Brain Health Institute, University of California, San Francisco; available at https://www.gbhi.org/ (last accessed 25 Jan 2022).

3 Yunusa, I, Alsumali, A, Garba, AE, Regestein, QR, Eguale, T. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: A network meta-analysis. JAMA Network Open 2019;2(3):e190828. doi:10.1001/jamanetworkopen.2019.0828 CrossRefGoogle ScholarPubMed.

4 Chiao, CY, Wu, HS, Hsiao, CY. Caregiver burden for informal caregivers of patients with dementia: A systematic review. International Nursing Review 2015;62(3):340–50. doi:10.1111/inr.12194 CrossRefGoogle ScholarPubMed.

5 Schneider, LS, Dagerman, KS, Insel, P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005;294(15):1934–43. doi:10.1001/jama.294.15.1934 CrossRefGoogle ScholarPubMed. PMID: 16234500.

6 Ballard, C, Hanney, ML, Theodoulou, M, Douglas, S, McShane, R, Kossakowski, K, Gill, R, Juszczak, E, Yu, LM, Jacoby, R; DART-AD investigators. The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomised placebo-controlled trial. Lancet Neurology 2009;8(2):151–7. doi: 10.1016/S1474-4422(08)70295-3 CrossRefGoogle Scholar. Epub 2009 Jan 8. PMID: 19138567.

7 Connors, MH, Ames, D, Boundy, K, Clarnette, R, Kurrle, S, Mander, A, Ward, J, Woodward, M, Brodaty, H. Predictors of Mortality in Dementia: The PRIME Study. Journal of Alzheimer’s Disease 2016;52(3):967–74. doi: 10.3233/JAD-150946 CrossRefGoogle ScholarPubMed. PMID: 27079702.

8 Zhai, Y, Yin, S, Zhang, D. Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease 2016;52(2):631–9. doi: 10.3233/JAD-151207 CrossRefGoogle ScholarPubMed. PMID: 27031490.